pilsicainide has been researched along with Sinoatrial Nodal Reentry Tachycardia in 1 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, YS | 1 |
| Honjo, H | 1 |
| Opthof, T | 1 |
| Okuno, Y | 1 |
| Nakagawa, H | 1 |
| Yamazaki, M | 1 |
| Harada, M | 1 |
| Takanari, H | 1 |
| Suzuki, T | 1 |
| Morishima, M | 1 |
| Sakuma, I | 1 |
| Kamiya, K | 1 |
| Kodama, I | 1 |
1 other study available for pilsicainide and Sinoatrial Nodal Reentry Tachycardia
| Article | Year |
|---|---|
Early termination of spiral wave reentry by combined blockade of Na+ and L-type Ca2+ currents in a perfused two-dimensional epicardial layer of rabbit ventricular myocardium.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Animal; Electrophysiolo | 2009 |